Any systemic treatment vs placebo
Apremilast · people with chronic plaque psoriasis
Any systemic treatment probably leads to higher apremilast compared with placebo (moderate certainty).
2 findings from 1 review
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes onlyRR 7.3 [4.26, 12.51]5 studies · 2029 participantsModerate
- Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis 2020 · Cochrane Headline outcomes onlyRR 0.86 [0.48, 1.51]6 studies · 2290 participantsLow